Patients News | pharmaphorum

News

NICE backs digital technologies for COPD rehab

More patients in England with chronic obstructive pulmonary disease (COPD) could soon be able to access rehabilitation programmes, after cost-effectiveness watchdog NICE b

News

Indivior bags $111m contract from US for overdose therapy

Indivior has secured a $111 million supply contract from the US federal government for its intranasal therapy for treating opioid overdose, in a further boost to the UK co

News

FDA OKs test to spot patients at risk of opioid use disorder

A test that can be given to patients before they are prescribed a course of opioid analgesics to check whether they are at risk of becoming dependent on the drugs has been

News

Owkin and MSD join forces on AI-powered digital pathology

Pharma group MSD has joined forces with Owkin to develop artificial intelligence-powered digital pathology diagnostics that could be used to identify patients suitable for

News

NICE’s new cholesterol guidance looks beyond statins

NICE has set a new target for cholesterol levels in people who have had a heart attack or stroke to reduce the risk of them having another, encouraging the use of addition

News

Enrolment starts in trial of AI-powered Parkinson’s therapy

Patient recruitment is now underway in a clinical trial of Newel Health’s digital therapeutic for Parkinson’s disease, which hopes to show it can enhance the efficacy of t

NICE backs digital technologies for COPD rehab

Indivior bags $111m contract from US for overdose therapy

FDA OKs test to spot patients at risk of opioid use disorder

Owkin and MSD join forces on AI-powered digital pathology

NICE’s new cholesterol guidance looks beyond statins

Enrolment starts in trial of AI-powered Parkinson’s therapy

Precision medicine in action, with Cary Claiborne

How to meet your physicians where they are online

News

Editor's Picks